This was an analysis of longitudinal data from individuals transitioning through menopause, published in Fertility and Sterility. Researchers followed a cohort of midlife women with repeated blood tests over time. They measured AMH and estradiol levels across the late reproductive years and menopause transition. Primary outcomes were patterns and timing of changes in AMH and estradiol relative to the final menstrual period.
AMH did not simply decline in a straight line; many participants showed a rebound or temporary increase in AMH as they neared menopause. Following this AMH rebound, estradiol levels often rose and then later declined as menopause approached. These patterns suggest dynamic ovarian activity in late reproductive age, with multiple hormonal inflection points. The analysis emphasizes that a single AMH or estradiol measurement may misrepresent true menopausal stage.
Participants were a specific research cohort and may not represent all racial, ethnic, or health backgrounds. Hormone measurements depend on assay type, timing in the cycle, and lab variability, which can affect accuracy. The study describes patterns but does not prove why AMH and estradiol rebound (e.g., local ovarian changes vs. brain-hormone feedback loops). It does not give precise rules for predicting menopause timing or fertility from these rebounds, so results should be applied cautiously and always with clinician guidance.
The study supports a more nuanced view of ovarian aging, where perimenopause includes oscillating hormone patterns rather than a smooth fadeout. This fits with clinical experience of irregular cycles, fluctuating symptoms, and variable lab values in the 40s. It challenges the use of one-time AMH readings as a firm predictor of time to menopause or fertility potential in late reproductive life. While consistent with some prior small studies, more work is needed across diverse populations and with standardized assays.
Do not rely on a single AMH or estradiol result to decide if you are “almost menopausal” or “out of eggs.” Expect ups and downs in cycles, symptoms, and hormone levels during the transition; this can be normal and not always a sign of sudden ovarian failure. Cycle tracking, symptom charting, and repeated labs over time can give a more accurate picture than one test. A restorative approach would look at hormones alongside sleep, stress, thyroid, insulin resistance, inflammation, and nutrient status to understand the full picture.
This study suggests that as you move toward menopause, your hormone levels may wobble rather than slide down smoothly. AMH, a marker often used to estimate egg supply, may go down, then rise again for a time, and then fall, while estrogen may also have a late rise before dropping. This can explain why periods and symptoms (like hot flashes, mood changes, and sleep issues) can feel unpredictable in your 40s and early 50s. For your fertility or hormone health, it means your care team should look at patterns over time, your cycle charts, and other root causes (like thyroid, blood sugar, inflammation, and stress) instead of making big decisions on one lab result alone.
Key pearl: late-reproductive and perimenopausal ovarian function appears more dynamic than a monotonic AMH decline; some individuals demonstrate AMH rebound followed by estradiol elevation before final decline. Clinically, be cautious using single AMH values in the late 30s–50s to predict menopause timing, counsel on fertility potential, or justify definitive treatments (e.g., oophorectomy, permanent contraception, or stopping restorative interventions). Within a restorative framework, consider serial AMH, estradiol, FSH, LH, progesterone, and cycle charting to map transition stages and distinguish physiological fluctuation from pathologic states (e.g., POI, hypothalamic dysfunction, thyroid disease, hyperprolactinemia, PCOS phenotype in aging). Integrate assessment of metabolic and inflammatory status (A1c or OGTT, fasting insulin, lipids, hs-CRP), thyroid panel, vitamin D and iron indices, as these can modulate symptoms and ovarian responsiveness; avoid over-interpreting transient hormonal shifts without this broader context.
Educational insights, not a diagnosis or individualized treatment advice. Discuss findings with your own clinician. Visit Reproductive Health Insights to explore fertility resources.